IPP Bureau
Shreehas Tambe appointed as new chairman of CII's National Pharmaceutical Committee
By IPP Bureau - June 06, 2026
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Alembic Pharma receives USFDA approval for Haloperidol tablets
By IPP Bureau - June 06, 2026
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
Dr. L H Hiranandani Hospital expands cancer care with advanced radiation therapy unit
By IPP Bureau - June 06, 2026
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
Lupin secures U.S. FDA approval for interchangeable biosimilar Ranibizumab
By IPP Bureau - June 06, 2026
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Sanofi launches AI-powered agent for sales representatives
By IPP Bureau - June 06, 2026
Built on Snowflake Cortex AI, the agent enables representatives to generate comprehensive pre-call plans through a single conversational interface
DBT highlights role of biomanufacturing in climate action
By IPP Bureau - June 06, 2026
The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development
Agappe Diagnostics appoints Rahul Raman Nair as CHRO
By IPP Bureau - June 06, 2026
Rahul brings over 17 years of experience in human resources leadership across the healthcare, banking, information technology, and FMCG sectors
Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies
By IPP Bureau - June 05, 2026
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
Aurobindo Pharma receives USFDA nod for generic Tofacitinib tablets
By IPP Bureau - June 05, 2026
Approval for generic version of Xeljanz enables immediate launch and strengthens Aurobindo’s U.S. portfolio with its 586th ANDA approval
Suven Life reports positive interim review for phase 3 Alzheimer’s therapy
By IPP Bureau - June 05, 2026
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Kaushik Deb elevated to Vice President at Mankind Pharma
By IPP Bureau - June 05, 2026
Seasoned pharma leader recognized for driving sales excellence, marketing strategy, and business growth
CBC India partners with Metalco-Alupack to strengthen pharma aluminium packaging solutions
By IPP Bureau - June 05, 2026
Exclusive partnership to expand access to high-quality seamless anodized aluminium packaging for sterile APIs and pharmaceutical products across India.
Glenmark launches generic Lacosamide Injection USP in US Market
By IPP Bureau - June 05, 2026
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
Rahul Pasumarthy joins Apollo Hospitals as Vice President – Apollo International
By IPP Bureau - June 05, 2026
Healthcare industry leader returns to India to support Apollo Hospitals’ global expansion and advance the ‘Heal in India, Heal by India’ vision
Aurobindo Pharma launches TheraNym, India’s largest biologics CMO
By IPP Bureau - June 05, 2026
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
